Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MB Biotech
United Statespmc.ncbi.nlm.nih.gov ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
MB Biosciences is an active, privately-owned life science company specializing in high-quality preclinical services and products. It provides animal organ-derived primary cells, custom hepatocyte isolation, various primary cell-based assays, animal model services, and ready-to-use permeability systems to pharmaceutical companies, biotech firms, and academic labs. Its offerings support drug development by enabling studies on drug metabolism, pharmacokinetics/pharmacodynamics (PK/PD), genotoxicity, oncology models, and more.
- Modalities
- Primary cell-based products3D cell culture systemsAnimal models
- Industry
- Drug Discovery Services
Beyond the preview
Go deeper on MB Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MB Biotech.